Here are the Form 4 insider transactions from AvePoint, Inc. (AVPT) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow AVPT and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full AVPT filings page.
AvePoint, Inc. insider entities reported planned stock sales. Trusts and LLCs associated with Executive Chairman and director Gong Xunkai sold 32,002 shares of common stock on January 12, 2026 at $13.66 per share and 27,998 shares on January 13, 2026 at $13.39 per share. Both transactions were indirect, reported as "Held by trusts and LLCs."
After these sales, entities associated with Mr. Gong beneficially owned 14,948,666 shares and 14,920,668 shares, respectively, on an indirect basis. The sales were effected under a Rule 10b5-1 trading plan adopted by the reporting person on June 22, 2025, and the report notes that he may be deemed to beneficially own certain affiliate- and trust-held shares while disclaiming beneficial ownership except to the extent of his pecuniary interest.
AvePoint director and Chief Legal Officer Brian Michael Brown reported insider equity transactions involving company stock and awards. On December 12, 2025, he acquired 21,000 shares of AvePoint common stock in connection with the exercise of stock options at a reported price of $13.89 per share. In a related exempt transaction under Rule 16b-3, 5,010 shares were withheld by AvePoint to satisfy the exercise price or tax obligations, rather than sold at his discretion. After these transactions, he beneficially owned 645,048 shares of common stock and restricted stock units in total, and held 2,265,102 stock options, all reported as directly owned.
AvePoint, Inc.’s chief financial officer reported a routine tax-related share withholding connected to equity compensation. On 12/12/2025, 6,120 shares of common stock were withheld at $13.89 per share to cover income tax obligations arising from the vesting or settlement of restricted stock units (RSUs) granted under the company’s 2021 Equity Incentive Plan.
This exempt transaction did not reflect a discretionary sale by the officer. After the withholding, the officer beneficially owns 200,130 shares of AvePoint common stock, including both regular shares and vested and unvested RSUs, each RSU representing the right to receive one share upon vesting.
AvePoint, Inc.'s Chief Executive Officer, who is also a director, reported an automatic tax-withholding transaction involving company stock. On 12/12/2025, 2,914 shares of AvePoint common stock were withheld by the company at a price of $13.89 per share to satisfy income tax obligations triggered by the vesting or settlement of restricted stock units (RSUs) granted under the 2021 Equity Incentive Plan. The filing characterizes this as an exempt Rule 16b-3 transaction and notes that it does not represent a discretionary trade by the insider. After this withholding, the reporting person beneficially owned 2,150,588 shares of AvePoint common stock, including both non-RSU shares and vested and unvested RSUs.
AvePoint, Inc. disclosed that its executive chairman and director had 4,025 shares of common stock withheld on December 12, 2025 to satisfy tax and related obligations arising from the vesting or settlement of equity awards, at a price of $13.89 per share. The company explains this was an exempt, non-discretionary transaction in which shares were delivered or withheld to cover income tax withholding and remittance obligations.
The reported holdings after this event total 759,677 shares beneficially owned directly, which include both non‑RSU common stock and aggregate vested and unvested restricted stock units granted under AvePoint’s 2021 Equity Incentive Plan. Each RSU represents the right to receive one share of common stock upon vesting.